FDA 483 - B Positive National Blood Services

An FDA inspection of B Positive National Blood Services in Easton, Pennsylvania, from November 5-7, 2024, revealed two significant observations. The firm failed to recalibrate a critical device used for quality control checks of collection equipment and did not conduct a required performance qualification study for freezers used to store Source Plasma units prior to their use.